2.3. Chemerin Decreased the Receptor Activator of Nuclear Factor Kappa-Β Ligand (RANKL)/Osteoprotegerin (OPG) Ratio in Osteoblastic Cells Treated with Conditioned Medium from Metastatic Breast Cancer Cells. Here, TNFSF11 is linked to breast carcinoma.